The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Babu Yarlagadda S since 2009.
This trader's CIK number is 1452635.
At the time of last reporting, Babu Yarlagadda S was the Chief Discovery Officer of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | BCRX | 0 | $0 | 20,000 | $343,200 | 0 | $0 |
| 2021 | BCRX | 0 | $0 | 30,100 | $367,220 | 112,000 | $500,760 |
| 2019 | BCRX | 25,000 | $36,250 | 0 | $0 | 31,874 | $38,248 |
| 2018 | BCRX | 0 | $0 | 0 | $0 | 30,000 | $97,800 |
| 2016 | BCRX | 0 | $0 | 30,000 | $121,799 | 0 | $0 |
| 2015 | BCRX | 0 | $0 | 60,000 | $629,249 | 0 | $0 |
| 2014 | BCRX | 0 | $0 | 40,642 | $510,869 | 51,995 | $310,602 |
| 2012 | BCRX | 0 | $0 | 31,749 | $134,448 | 84,580 | $35,239 |
| 2009 | BCRX | 0 | $0 | 30,000 | $288,139 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-07 | BCRX | Sale | 20,000 | 17.16 | 343,200 |
| 2021-12-07 | BCRX | Option Ex | 62,000 | 4.73 | 293,260 |
| 2021-12-07 | BCRX | Sale | 30,100 | 12.20 | 367,220 |
| 2021-02-19 | BCRX | Option Ex | 50,000 | 4.15 | 207,500 |
| 2019-11-18 | BCRX | Buy | 25,000 | 1.45 | 36,250 |
| 2019-01-31 | BCRX | Option Ex | 31,874 | 1.20 | 38,248 |
| 2018-03-06 | BCRX | Option Ex | 30,000 | 3.26 | 97,800 |
| 2016-08-25 | BCRX | Sale | 30,000 | 4.06 | 121,799 |
| 2015-03-19 | BCRX | Sale | 12,105 | 10.16 | 122,986 |
| 2015-03-05 | BCRX | Sale | 37,400 | 10.59 | 396,066 |
| 2015-03-04 | BCRX | Sale | 10,495 | 10.50 | 110,197 |
| 2014-03-04 | BCRX | Option Ex | 28,816 | 7.32 | 210,933 |
| 2014-03-04 | BCRX | Sale | 40,642 | 12.57 | 510,869 |
| 2014-02-24 | BCRX | Option Ex | 23,179 | 4.30 | 99,669 |
| 2012-03-02 | BCRX | Sale | 837 | 4.78 | 4,000 |
| 2012-02-29 | BCRX | Option Ex | 53,668 | .00 | 0 |
| 2012-02-22 | BCRX | Sale | 30,912 | 4.22 | 130,448 |
| 2012-02-22 | BCRX | Option Ex | 30,912 | 1.14 | 35,239 |
| 2009-10-26 | BCRX | Sale | 6,400 | 10.85 | 69,420 |
| 2009-10-21 | BCRX | Sale | 200 | 10.00 | 2,000 |
| 2009-10-20 | BCRX | Sale | 3,400 | 10.00 | 34,000 |
| 2009-09-23 | BCRX | Sale | 20,000 | 9.14 | 182,719 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Babu Yarlagadda S (Chief Discovery Officer of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.